about
Developing Global Norms for Sharing Data and Results during Public Health EmergenciesStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyT Cell Immunity and Zika Virus Vaccine Development.Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolGain-of-Function Research and the Relevance to Clinical Practice.Opium trade and the spread of HIV in the Golden CrescentA comparison of HIV detection rates using routine opt-out provider-initiated HIV testing and counseling versus a standard of care approach in a rural African settingEffect of treating co-infections on HIV-1 viral load: a systematic reviewMultiple co-circulating HIV-1 subtypes in the Middle East and North AfricaEvaluation of candidate vaccine approaches for MERS-CoV.Novel antigens for RSV vaccines.Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.Treatment strategies for Middle East respiratory syndrome coronavirus.Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project.Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progressionToward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults.Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting.Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab.MERS-CoV vaccine candidates in development: The current landscape.Status of vaccine research and development of vaccines for Staphylococcus aureus.Predictors of HIV serostatus among HIV discordant couples in Lusaka, Zambia and female antenatal clinic attendants in Kigali, Rwanda.Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.AIDS epidemic: Iran needs global support to fight HIV.Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward".The descriptive epidemiology of intentional burns in the United States: an analysis of the National Burn Repository.Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil.Association between upper extremity injuries and side airbag availability.Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation.Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape.HIV and helminths: time for a new direction.MSJAMA. International health: purpose, value, challenges.Book Review Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure By Paul A. Offit. 298 pp., illustrated. New York, Columbia University Press, 2008. $24.95. 978-0-231-14636-4STUDENTJAMA. Medicine and spirituality.Faculty of 1000 evaluation for Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP VaccinationFaculty of 1000 evaluation for Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trialFaculty of 1000 evaluation for Gut microbiomes of Malawian twin pairs discordant for kwashiorkorFaculty of 1000 evaluation for Antibiotics as part of the management of severe acute malnutritionFaculty of 1000 evaluation for Deworming of intestinal helminths reduces HIV-1 subtype C viremia in chronically co-infected individuals
P50
Q23331292-27CFDC9C-F71A-45A4-8E41-61C5654D4EACQ27677570-31BE4BD6-1570-49C1-986E-FB850AF2CBC3Q30145526-D43D273A-87C1-4C5D-B707-D818AD013841Q30277992-4A087B6E-9DF1-47F6-9DC7-3892F092C1E4Q30379683-C43309FC-C2D5-4D06-8598-F5383D28DF11Q33922836-7FB5A95B-408E-40F5-BE2E-000EEA91D8ECQ34470827-4AE5F896-9F3F-46D9-A60F-E8E2DF20F30CQ34767216-B0C0EF3F-E671-4669-A73F-3A7A7A8C3C12Q35853802-5D2B90EC-1926-4F33-9744-EA6D4BA4A83EQ35917397-A713A865-0C07-4E57-B44A-DFF3F984CD9BQ36005960-E91D8749-6301-4A7B-AFB4-E292CBDE4715Q36353767-221C7B69-C73F-4D79-844F-C75DE48B4B9AQ36555622-C5D21B74-BCAB-4BDC-AC51-D0B2783D5A11Q37084526-F7AF4610-FEA3-41FC-AAFE-9D3973BF3C19Q37142200-156491E2-2FA1-400D-A8C3-1A7B9FC107E8Q37169882-4BCCAFC7-022A-433C-9E6B-F8BFFE805ADBQ37315433-8899688A-87CA-4D9A-9D43-843DD639B605Q37358427-17AA7727-97E6-4DBC-AAD7-4933F7A659D6Q38702381-739E8D5E-A070-4D49-9BB8-9EA176E55A6FQ38809401-6352A00A-F7C6-48D3-BF95-986E9B7AC658Q38815039-1085ACD5-CA92-4F48-A758-7C6C09BBB209Q44570829-6BBE269C-E268-4DCC-A176-B0C14A1CF179Q45323630-18C8C3E2-BDAA-408D-BCF9-BD0624642CFAQ46385259-7D1FA94A-C02B-4F8D-B6E6-EC851D0E8112Q46678218-8B734FFB-8F06-4280-90EE-A1386018A13AQ47298125-466AE17A-6BA3-4461-921F-EA4A264F9704Q47550295-A7638A85-4557-4D0C-B9F3-0F027CE5483EQ47716449-A42B2106-4CE0-4E59-AC56-A3D8E32F4F18Q50208553-C25F4083-CF0E-4AC0-BB4B-0DA73163EFACQ50793231-E8C2BF5D-3696-4AE9-9C5F-AFE74769D444Q51149122-7A4CADA2-DAF4-4C77-B308-DEC7B297AA4CQ51863938-FC033302-2F9D-4CD6-B9BA-F1B77D3014C6Q53308588-7476AF5F-A768-48BC-A026-B9B02FAE5325Q54228707-F3E08C64-19C6-4A90-8EA6-C488CEE21EE5Q54734138-94F627DE-EF20-4487-9800-3D7E0DB8965EQ54980696-A5748A22-E17A-45A5-956F-0940CA672A84Q54980709-3953BCAF-6905-40D9-9374-60B1E05C615EQ54980715-E416548F-AA66-498C-B0A6-D7B0AA340C59Q54980718-F7FA6F7B-1B54-4613-9F68-68D21BE0ED6BQ54980719-90BC7906-BA67-4AE7-916A-B4C9EF325A2B
P50
name
Kayvon Modjarrad
@ast
Kayvon Modjarrad
@en
Kayvon Modjarrad
@es
Kayvon Modjarrad
@nl
type
label
Kayvon Modjarrad
@ast
Kayvon Modjarrad
@en
Kayvon Modjarrad
@es
Kayvon Modjarrad
@nl
prefLabel
Kayvon Modjarrad
@ast
Kayvon Modjarrad
@en
Kayvon Modjarrad
@es
Kayvon Modjarrad
@nl